2012 Press Releases

Second China CyberKnife® Forum Provides Platform to Share Knowledge and Experience on Accuray’s CyberKnife System SUNNYVALE, Calif., December 21, 2012 – Accuray Incorporated (Nasdaq: ARAY) announced today that about 100 attendees from hospitals using CyberKnife® Systems in China were brought together at the Second China CyberKnife Forum, co-organized by the Radiation Oncology Committees of Chinese Anti-Cancer Association and Chinese Medical Association, which was held at Huashan Hospital, Shanghai on November 23-24, 2012. Read More »
Accuray Incorporated’s CEO to Speak at 31st Annual J.P. Morgan Healthcare Conference SUNNYVALE, Calif., December 20, 2012 – Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its president and chief executive officer, Joshua H. Levine, is scheduled to present at the J.P. Morgan Healthcare Conference in San Francisco on Monday, January 7, 2013 at 9:00 a.m. PST/12:00 p.m. EST. Read More »
Accuray Incorporated to Speak at 23rd Annual Oppenheimer Healthcare Conference SUNNYVALE, Calif., December 6, 2012 – Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Oppenheimer Healthcare Conference in New York on Thursday, December 13, 2012 at 11:10 a.m. EST/8:10 a.m. PST. Read More »
Accuray Continues Global Expansion in South Asia and Announces the First Two CyberKnife® VSI™ Systems in India SUNNYVALE, Calif., November 21, 2012 – Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that Medanta - The Medicity Cancer Institute, and the Roentgen-BLK Super Speciality Hospital both recently acquired and started treating patients with the CyberKnife® VSI™ System the premier solution for full-body radiosurgery marking the first-in-country CyberKnife VSI Systems in India. Read More »
Accuray Incorporated to Speak at Lazard Capital Markets Healthcare Conference SUNNYVALE, Calif., November 9, 2012 – Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Lazard Capital Markets Healthcare Conference in New York on Tuesday November 13, 2012 at 3:30 p.m. EST/12:30 p.m. PST. Read More »
Accuray Announces Results for First Quarter Fiscal 2013 SUNNYVALE, Calif., November 7, 2012 – Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today financial results for the first quarter of fiscal 2013 that ended September 30, 2012. Non-GAAP results are provided to enhance understanding of Accuray’s ongoing core results of operations. Read More »
90 Presentations at Leading Radiation Oncology Meeting Demonstrate the Breadth and Depth of Clinical Evidence for Accuray Technologies SUNNYVALE, Calif., November 7, 2012 – Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that studies presented at the 54th Annual American Society for Radiation Oncology (ASTRO) Meeting in Boston, October 28-31, 2012 continue to demonstrate the unique strengths of the CyberKnife® and TomoTherapy® Systems. Podium and poster presentations on a variety of indications including prostate, lung, liver, breast and head and neck, showcased Accuray’s position as a leader in radiation oncology. Read More »
Presentations at Leading Radiation Oncology Meeting Highlight CyberKnife Prostate Outcomes from Patients at More Than 40 Centers SUNNYVALE, Calif., November 5, 2012 – Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today clinical findings using non-invasive CyberKnife® stereotactic body radiation therapy (SBRT) for the treatment of prostate cancer. Two studies presented at the 54th Annual American Society for Radiation Oncology (ASTRO) Meeting in Boston were selected by ASTRO for presentation to the media at a prostate-focused press conference on Tuesday, October 30, 2012, for which the use of CyberKnife SBRT for prostate cancer represented half of the press conference’s focus. Read More »

Seiten